Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | TYMP | P19971 | 1/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14849894 | 0.89 | PGR (0.33) | KDM4EMAPTKMT2A | |
| SCHEMBL14849739 | 0.88 | PGR (0.33) | MEN1MAPTKMT2A | |
| SCHEMBL14849846 | 0.86 | MAPT (0.31) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL15681218 | 0.82 | KDM4E (0.30) | KDM4EKMT2A | |
| SCHEMBL2609847 | 0.82 | TUBB4A (0.33) | — | |
| SCHEMBL15681187 | 0.80 | ALOX5 (0.35) | MEN1KMT2A | |
| SCHEMBL20909130 | 0.79 | — | — | |
| SCHEMBL17245721 | 0.79 | MEN1 (0.40) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL26813147 | 0.79 | MAPT (0.33) | KDM4EMAPT | |
| SCHEMBL15681225 | 0.78 | MAPK14 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9309197-B2 | Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-12 | — | — | US | disclosed |
| US-20130087768-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE HETEROCYCLIC COMPOUND, AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-04-11 | — | — | US | disclosed |
| US-20130087768-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE HETEROCYCLIC COMPOUND, AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130087768-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE HETEROCYCLIC COMPOUND, AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | DRD1, DRD2, DRD3 | KDM4E 2612/4885MEN1 1127/4885MAPT 1618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.